Adjunctive Hydrocortisone Improves Hemodynamics in Critically Ill Patients with Septic Shock: An Observational Study Using Transpulmonary Thermodilution

被引:1
作者
Jochheim, Leonie [1 ]
Jochheim, David [2 ]
Habenicht, Livia [3 ]
Herner, Alexander [3 ]
Ulrich, Joerg [3 ]
Wiessner, Johannes [3 ]
Heilmaier, Markus [3 ]
Rasch, Sebastian [3 ]
Schmid, R. M. [3 ]
Lahmer, T. [3 ]
Mayr, Ulrich [3 ]
机构
[1] Uniklinikum Essen, Klin Gastroenterol & Hepatol, Essen, Germany
[2] Med Versorgungszentrum MVZ Jochheim Med, Hattingen, Germany
[3] Tech Univ Munich, Med Klin & Poliklin 2, Klinikum Rechts Isar, Ismaninger Str 22, D-81675 Munich, Germany
关键词
septic shock; hydrocortisone; transpulmonary thermodilution; intensive care unit; vasopressor dependency index; cardiac power index; EXTRAVASCULAR LUNG WATER; INTERNATIONAL CONSENSUS DEFINITIONS; SEVERE SEPSIS; CARDIAC POWER; MORTALITY; FLUDROCORTISONE; GUIDELINES; MANAGEMENT; CARE;
D O I
10.1177/08850666231160664
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction: Septic shock is associated with high mortality and hemodynamic impairment. The use of corticoids is a common therapeutic tool in critically ill patients. However, data on the mechanisms and prognostic ability of hemodynamic improvement by adjunctive steroids are rare. This study primarily aimed to evaluate short-term effects of hydrocortisone therapy on catecholamine requirement and hemodynamics derived from transpulmonary thermodilution (TPTD) in 30 critically ill patients with septic shock and a 28 days mortality rate of 50%. Methods: Hydrocortisone was administered with an intravenous bolus of 200 mg, followed by a continuous infusion of 200 mg per 24 h. Hemodynamic assessment was performed immediately before as well as 2, 8, 16, and 24 h after the initiation of corticoids. For primary endpoint analysis, we evaluated the impact of hydrocortisone on vasopressor dependency index (VDI) and cardiac power index (CPI). Results: Adjunctive hydrocortisone induced significant decreases of VDI from 0.41 (0.29-0.49) mmHg(-1) at baseline to 0.35 (0.25-0.46) after 2 h (P < .001), 0.24 (0.12-0.35) after 8 h (P < .001), 0.18 (0.09-0.24) after 16 h (P < .001) and 0.11 (0.06-0.20) mmHg(-1) after 24 h (P < .001). In parallel, we found an improvement in CPI from 0.63 (0.50-0.83) W/m(2) at baseline to 0.68 (0.54-0.85) after 2 h (P = .208), 0.71 (0.60-0.90) after 8 h (P = .033), 0.82 (0.6-0.98) after 16 h (P = .004) and 0.90 (0.67-1.07) W/m(2) after 24 h (P < .001). Our analyses revealed a significant reduction in noradrenaline requirement in parallel with a moderate increase in mean arterial pressure, systemic vascular resistance index, and cardiac index. As a secondary endpoint, our results showed a significant decrease in lung water parameters. Moreover, changes in CPI (Delta CPI) and VDI (Delta VDI) after 24 h of hydrocortisone therapy revealed accurate prognostic ability to predict 28 days mortality (AUC = 0.802 vs 0.769). Conclusion: Adjunctive hydrocortisone leads to a rapid decrease in catecholamine requirement and a substantial circulatory improvement in critically ill patients with septic shock.
引用
收藏
页码:717 / 726
页数:10
相关论文
共 38 条
[1]   Severe Sepsis and Septic Shock REPLY [J].
Angus, Derek C. ;
van der Poll, Tom .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (21) :2063-2063
[2]   Septic shock [J].
Annane, D ;
Bellissant, E ;
Cavaillon, JM .
LANCET, 2005, 365 (9453) :63-78
[3]   Current epidemiology of septic shock - The CUB-Rea network [J].
Annane, D ;
Aegerter, P ;
Jars-Guincestre, MC ;
Guidet, B .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (02) :165-172
[4]   Hydrocortisone plus Fludrocortisone for Adults with Septic Shock [J].
Annane, D. ;
Renault, A. ;
Brun-Buisson, C. ;
Megarbane, B. ;
Quenot, J. -P. ;
Siami, S. ;
Cariou, A. ;
Forceville, X. ;
Schwebel, C. ;
Martin, C. ;
Timsit, J. -F. ;
Misset, B. ;
Benali, M. Ali ;
Colin, G. ;
Souweine, B. ;
Asehnoune, K. ;
Mercier, E. ;
Chimot, L. ;
Charpentier, C. ;
Francois, B. ;
Boulain, T. ;
Petitpas, F. ;
Constantin, J. -M. ;
Dhonneur, G. ;
Baudin, F. ;
Combes, A. ;
Bohe, J. ;
Loriferne, J. -F. ;
Amathieu, R. ;
Cook, F. ;
Slama, M. ;
Leroy, O. ;
Capellier, G. ;
Dargent, A. ;
Hissem, T. ;
Maxime, V. ;
Bellissant, E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (09) :809-818
[5]   Corticosteroids for treating sepsis in children and adults [J].
Annane, Djillali ;
Bellissant, Eric ;
Bollaert, Pierre Edouard ;
Briegel, Josef ;
Keh, Didier ;
Kupfer, Yizhak ;
Pirracchio, Romain ;
Rochwerg, Bram .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (12)
[6]   Critical Illness-Related Corticosteroid Insufficiency (CIRCI): A Narrative Review from a Multispecialty Task Force of the Society of Critical Care Medicine (SCCM) and the European Society of Intensive Care Medicine (ESICM) [J].
Annane, Djillali ;
Pastores, Stephen M. ;
Arlt, Wiebke ;
Balk, Robert A. ;
Beishuizen, Albertus ;
Briegel, Josef ;
Carcillo, Joseph ;
Christ-Crain, Mirjam ;
Cooper, Mark S. ;
Marik, Paul E. ;
Meduri, Gianfranco Umberto ;
Olsen, Keith M. ;
Rochwerg, Bram ;
Rodgers, Sophia C. ;
Russell, James A. ;
Van den Berghe, Greet .
CRITICAL CARE MEDICINE, 2017, 45 (12) :2089-2098
[7]   The standard of care of patients with ARDS: ventilatory settings and rescue therapies for refractory hypoxemia [J].
Bein, Thomas ;
Grasso, Salvatore ;
Moerer, Onnen ;
Quintel, Michael ;
Guerin, Claude ;
Deja, Maria ;
Brondani, Anita ;
Mehta, Sangeeta .
INTENSIVE CARE MEDICINE, 2016, 42 (05) :699-711
[8]   AN EARLY TEST OF SURVIVAL IN PATIENTS WITH THE ADULT RESPIRATORY-DISTRESS SYNDROME - THE PAO2/FLO2 RATIO AND ITS DIFFERENTIAL RESPONSE TO CONVENTIONAL THERAPY [J].
BONE, RC ;
MAUNDER, R ;
SLOTMAN, G ;
SILVERMAN, H ;
HYERS, TM ;
KERSTEIN, MD ;
URSPRUNG, JJ .
CHEST, 1989, 96 (04) :849-851
[9]   Discordant nature of Cd in PbSe: off-centering and core-shell nanoscale CdSe precipitates lead to high thermoelectric performance [J].
Cai, Songting ;
Hao, Shiqiang ;
Luo, Zhong-Zhen ;
Li, Xiang ;
Hadar, Ido ;
Bailey, Trevor ;
Hu, Xiaobing ;
Uher, Ctirad ;
Hu, Yan-Yan ;
Wolverton, Christopher ;
Dravid, Vinayak P. ;
Kanatzidis, Mercouri G. .
ENERGY & ENVIRONMENTAL SCIENCE, 2020, 13 (01) :200-211
[10]  
Cecconi M, 2010, MINERVA ANESTESIOL, V76, P1010